NorthView Acquisition today priced its initial public offering of 16.5 million units at $10 each. The units begin trading today on the Nasdaq under the NVACU.
Although the SPAC offered 1.5 million more units than cited in its amended registration two weeks ago, plans for the initial offering filed in June listed 18 million units.
Each unit consists of one share, one right, and one-half of a redeemable warrant. Each right entitles the holder to one-tenth of a share, and whole warrants are redeemable at $11.50 for a share.
I-Bankers Securities is sole book-running manager for the offering. Dawson James is co-manager.
The SPAC expects to target small-cap healthcare companies that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space. Read more.
